2023
DOI: 10.1101/2023.01.21.23284855
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Safety of bivalent omicron-containing mRNA-booster vaccines: a nationwide cohort study

Abstract: Background: Safety data to support bivalent omicron-containing mRNA-booster vaccination are lacking. Methods: In a Danish nationwide cohort study from 1 January 2021 to 10 December 2022, we examined the association between bivalent omicron-containing mRNA-booster vaccination as a fourth Covid-19 vaccine dose and risk of adverse events in individuals aged ≥50 years. Using incidence rate ratios estimated with Poisson regression, we compared the rates of hospital visits for 27 different adverse events in a 28-day… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 17 publications
0
0
0
Order By: Relevance